|
|
Article: HemoBioTech Announces Addition of Dr. Roscoe M. Moore Jr. Former Us Assistant Surgeon General to Scientific Advisory Board.
- Article from:
- Business Wire
- Article date:
- March 12, 2009
CopyrightCOPYRIGHT 2009 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
DALLAS -- HemoBioTech (OTCBB:HMBT) (www.hemobiotech.com) announced today that Dr. Roscoe Moore has joined the HemoBioTech Scientific Advisory Board. Dr. Moore is a former US Assistant Surgeon General and has served with the United States Department of Health and Human Services (HHS) where he was responsible for development support within the Office of the Secretary, with primary emphasis on Continental Africa and other less developed countries of the world. He had served as an Epidemic Intelligence Service Officer with the US Centers for Disease Control and Prevention. He has also served as the Chief Epidemiologist with the Center for Devices and Radiological Health at the ...
Related newspaper, magazine, and journal articles:
|
|
Article: HemoBioTech Announces Exercise of Warrants By RENN Capital; ...
PR Newswire;
February 7, 2006 ;
700+ words
... ... we continue to advance our product, HemoTech(TM)," stated Dr. Arthur P. Bollon ... this exciting company and its product, HemoTech(TM)." About HemoBioTech, Inc. HemoBioTech is engaged in the development of HemoTech(TM), a novel human blood substitute ...
|
|